800-845-6913
Tuteur & Associates, LLC |
Knowledge is Power.
Have you or a loved on been injured by the use of Trasylol
Trasylol-Injury-Lawyers.com
Home
About Us
About Trasylol
Trasylol FDA
Trasylol News
Trasylol Press Releases
Contact Us
Contact us today.
First Name
Last Name
Email
Phone
Cell Phone
Street Address
City
State
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas.Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
Zip
Date of birth of injured person (mm/dd/yyyy)
Do you know if trasylol was used during surgery?
Please further describe side effects
Articles
FDA Patient Safety News: Trasylol
Manufacturer [Bayer] Removes Remaining Stocks of Trasylol
FDA MedWatch Alert - Trasylol (aprotinin injection) (10-25-07)
FDA MedWatch Alert - Trasylol (aprotinin injection) (11-5-07)
Detailed View: Trasylol Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- December 2006
Transcript of Second FDA Press Conference on Trasylol (11/5/07)
Transcript of FDA Press Conference on Trasylol (11/5/07)
FDA Statement Regarding New Trasylol Data (9-29-06)
FDA Revises Labeling for Trasylol (Aprotinin Injection) to Strengthen Safety Warnings and Limit Usage of Drug to Specific Situations (12-15-06)
Questions and Answers on Trasylol/Aprotinin (2-7-06)
Early Communication about an Ongoing Safety Review Trasylol/Aprotinin Injection (10-25-07)
FDA Issues Early Communication About an Ongoing Safety Review of Aprotinin Injection (10-26-07)
FDA Requests Marketing Suspension of Trasylol (11-5-07)
Headlines
FDA Patient Safety News: Trasylol
Marketing of Trasylol Suspended